FDA Label for Stay Awake
View Indications, Usage & Precautions
Stay Awake Product Label
The following document was submitted to the FDA by the labeler of this product Marc Glassman, Inc.. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Active Ingredient(S)
Caffeine 200mg
Purpose
Alertness aid
Uses
helps restore mental alertness or wakefulness when experiencing fatigue or drowsiness
Warnings
For occasional use only.
Do Not Use
- in children under 12 years of age
- as a substitute for sleep
When Using This Product
limit the use of caffeine- containing medications, foods or beverages because too much caffeine may cause nervousness, irritability, sleeplessness, and occasional rapid heartbeat.
The recommended dose of this product contains about as much caffeine as a cup of coffee.
Stop Use And Ask A Doctor If
fatigue or drowsiness persists or continues to occur.
Pregnancy/Breastfeeding
If pregnant or breast-feeding, ask a health professional before use.
Keep Out Of Reach Of Children
Keep out of reach of children.
In case of accidental overdose, get medical help or contact a Poison Control Center (1-800-222-1222) immediately.
Directions
- Adults and children 12 years of age and older: take 1 tablet not more often than every 3 to 4 hours
- Children under 12 years of age: do not use
Other Information
- store at room temperature 68°-77°F (20°-25°C)
- avoid excessive heat (greater than 100°F)
- do not use if carton is opened or blister unit is broken
Inactive Ingredients
croscarmellose sodium, D&C yellow #10 aluminum lake, dicalcium phosphate, FD&C yellow #6 aluminum lake, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, silicon dioxide, titanium dioxide
Principal Display Panel
* Please review the disclaimer below.
